181 related articles for article (PubMed ID: 37770284)
1. Validated medication deprescribing instruments for patients with palliative care needs: a systematic review.
de Andrade FK; Nunes RPI; Zanetti MOB; Zanetti ACB; Dos Santos M; de Oliveira AM; Carson-Stevens A; Pereira LRL; Varallo FR
Farm Hosp; 2024; 48(2):83-89. PubMed ID: 37770284
[TBL] [Abstract][Full Text] [Related]
2. Validated medication deprescribing instruments for patients with palliative care needs palliative care: A systematic review.
de Andrade FK; Ignacio Nunes RP; Barboza Zanetti MO; Barboza Zanetti AC; Dos Santos M; de Oliveira AM; Carson-Stevens A; Leira Pereira LR; Rossi Varallo F
Farm Hosp; 2024; 48(2):T83-T89. PubMed ID: 38016841
[TBL] [Abstract][Full Text] [Related]
3. Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail Criteria.
Curtin D; Jennings E; Daunt R; Curtin S; Randles M; Gallagher P; O'Mahony D
J Am Geriatr Soc; 2020 Apr; 68(4):762-769. PubMed ID: 31868920
[TBL] [Abstract][Full Text] [Related]
4. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
[TBL] [Abstract][Full Text] [Related]
5. Deprescribing in palliative care.
Thompson J
Clin Med (Lond); 2019 Jul; 19(4):311-314. PubMed ID: 31308110
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.
Omuya H; Nickel C; Wilson P; Chewning B
Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330
[TBL] [Abstract][Full Text] [Related]
8. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy in Palliative Care: Two Deprescribing Tools Compared with a Clinical Review.
McNeill R; Hanger HC; Chieng J; Chin P
J Palliat Med; 2021 May; 24(5):661-667. PubMed ID: 32991250
[No Abstract] [Full Text] [Related]
10. The value of deprescribing in older adults with dementia: a narrative review.
Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
[No Abstract] [Full Text] [Related]
11. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
[TBL] [Abstract][Full Text] [Related]
12. Deprescribing in palliative patients with cancer: a concise review of tools and guidelines.
van Merendonk LN; Crul M
Support Care Cancer; 2022 Apr; 30(4):2933-2943. PubMed ID: 34617161
[TBL] [Abstract][Full Text] [Related]
13. How "age-friendly" are deprescribing interventions? A scoping review of deprescribing trials.
Wang J; Shen JY; Conwell Y; Podsiadly EJ; Caprio TV; Nathan K; Yu F; Ramsdale EE; Fick DM; Mixon AS; Simmons SF
Health Serv Res; 2023 Feb; 58 Suppl 1():123-138. PubMed ID: 36221154
[TBL] [Abstract][Full Text] [Related]
14. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
[TBL] [Abstract][Full Text] [Related]
16. Impact of Deprescribing Interventions in Older Hospitalised Patients on Prescribing and Clinical Outcomes: A Systematic Review of Randomised Trials.
Thillainadesan J; Gnjidic D; Green S; Hilmer SN
Drugs Aging; 2018 Apr; 35(4):303-319. PubMed ID: 29541966
[TBL] [Abstract][Full Text] [Related]
17. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.
Page AT; Clifford RM; Potter K; Schwartz D; Etherton-Beer CD
Br J Clin Pharmacol; 2016 Sep; 82(3):583-623. PubMed ID: 27077231
[TBL] [Abstract][Full Text] [Related]
18. Does Deprescribing Improve Quality of Life? A Systematic Review of the Literature.
Pruskowski JA; Springer S; Thorpe CT; Klein-Fedyshin M; Handler SM
Drugs Aging; 2019 Dec; 36(12):1097-1110. PubMed ID: 31598908
[TBL] [Abstract][Full Text] [Related]
19. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2.
Curtin D; Gallagher P; O'Mahony D
Age Ageing; 2021 Feb; 50(2):465-471. PubMed ID: 32997135
[TBL] [Abstract][Full Text] [Related]
20. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation.
Lavan AH; Gallagher P; Parsons C; O'Mahony D
Age Ageing; 2017 Jul; 46(4):600-607. PubMed ID: 28119312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]